The apnea-hypopnea index (AHI) is a scale that tells whether you have a sleep disorder called apnea and, if so, how serious it is. Sleep apnea is when you stop breathing for 10 seconds or more ...

Sleep Better Columbus is now offering FDA-cleared oral appliance therapy for patients diagnosed with mild to moderate ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Topline data were announced from a phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in participants with obstructive sleep apnea.

A recent post-hoc analysis of the SURMOUNT-OSA trials revealed that tirzepatide significantly improves obstructive sleep ...

But in recent months, various media outlets and social media accounts have suggested taping your mouth closed before going to ...

Apnimed’s star sleep apnea asset has hit the latest landmark on its march down victory road. | Apnimed’s star sleep apnea ...

Logistic regression analysis showed that only AHI was a predictor of daytime hypercapnia ... daytime hypercapnia may be directly linked to sleep apnea in a subgroup of patients with OSAS.

Home sleep apnea tests (HSATs) use sophisticated sensors and algorithms to monitor your breathing patterns, oxygen levels, ...

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea. Research shows that it considerably improves the level of AHI in patients with ...

“REM sleep is when your brain does some of its most important cleanup and memory storage work,” said co-corresponding author ...

Research has provided key insight into sleep apnea and its connection to the brain, as well as uncovering a potential new diagnostic tool for obstructive sleep apnea — one that could be used ...